December 7, 2021
Changing the Future of Women’s Health
Good Clean Love advocates for the use of MatTek's EpiVaginal as a more relevant method for testing women’s personal care products.
News
September 21, 2021
BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol
CELLINK, Visikol, and MatTek have joined forces to present customers a first of its kind 3D biomanufacturing and in vitro analysis service.
July 6, 2021
Visikol Partners with MatTek
It was announced today that Visikol will leverage the MatTek portfolio of advanced cell culture models within its drug discovery services.
June 23, 2021
EpiDerm™ approved by OECD as stand-alone in-vitro test method for phototoxicity
MatTek Life Sciences, a subsidiary of CELLINK, today announced the OECD acceptance of the EpiDerm Phototoxicity Test for Test Guideline 498.
March 10, 2021
MatTek Acquired By CELLINK
MatTek Corporation, a Boston-area life sciences company, announced today that it has been acquired by CELLINK.
